12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

AX200: Phase II data

The double-blind, European Phase II AXIS 2 trial in 328 patients who had an acute ischemic stroke showed that IV AX200 missed the primary endpoint of significantly improving mean mRS scores vs. placebo...

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >